Latest stories on ATNM
Targeted Alpha Therapy Market Size to Hit USD 11.52 Billion by 2035 from USD 1.25 Billion in 2025 at CAGR of 24.9% - SNS Insider
GlobeNewswire63 · neutralgeneral
Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
PR Newswire55 · neutralproduct/pr
Actinium Pharmaceuticals, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
StockTitan56 · neutralproduct/pr
Defence Therapeutics Expands Radiopharmaceutical Development Strategy with Alpha and Beta-Emitter Programs
StockTitan56 · neutralproduct/pr
Actinium Pharmaceuticals, Inc. (ATNM) files 8-K
SEC 8-K50 · neutralgeneral
Ratio Therapeutics Enters Strategic Actinium-225 Supply Agreement with PanTera to Support Radiopharmaceutical Development Programs
PR Newswire63 · neutralproduct/pr
Actinium Submits NYSE Compliance Plan to Restore Listing
TipRanks55 · neutralgeneral
Actinium Pharmaceuticals, Inc. (ATNM) files 8-K
SEC 8-K50 · neutralgeneral
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs
PR Newswire63 · neutralproduct/pr
Actinium Pharmaceuticals Receives Two Patent Allowances Spanning Its Actimab-A and Iomab-ACT Programs | ATNM Stock News
StockTitan63 · neutralproduct/pr
Niowave Breaks Ground on New $75 Million Production Facility to Advance Targeted Cancer Therapies
PR Newswire67 · bullishproduct/pr
TerraPower Isotopes Breaks Ground on World's Largest Actinium-225 Manufacturing Facility in Philadelphia
PR Newswire73 · bullishproduct/pr